
Erectile Dysfunction and Cardiovascular Disease: Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors in Men With Both Conditions
Keywords: BPH; benign prostatic hyperplasia; CAD; coronary artery disease; CI; confidence interval; CVD; cardiovascular disease; ED; erectile dysfunction; EF; ejection fraction; HbA1c; hemoglobin A1c; HDL-C; high-density lipoprotein cholesterol; IIEF; International